PHENICARBAZIDE

Phenicarbazide is a hydrazide derivative with antimicrobial and antitubercular potential, believed to inhibit bacterial metabolic pathways. It has been used experimentally. Side effects may include nausea, dizziness, rash, liver enzyme elevations, and allergic reactions; safety data are limited, and clinical use is uncommon today. Only GMP materials will be supplied, logistics all according to GDP.

SKU: e8ae3c6b0310 Category: Tag:

Product Description


Mechanism of Action

PHENICARBAZIDE demonstrates a multidimensional biochemical activity pattern, affecting enzymeregulated catalytic networks, receptormediated intracellular signalling, mitochondrial respiratory pathways, oxidativestress regulation, ionchannel behaviour, cytoskeletal mechanics and transcriptionfactor network modulation. Structural evidence suggests potential interactions with catalytic residues, allosteric domains, transmembrane protein complexes, regulatory scaffolds and intracellular signalling intermediates. These interactions allow PHENICARBAZIDE to influence phosphorylation kinetics, secondmessenger signalling (Ca²⁺, cAMP, IP, DAG), redoxbuffering systems, ATP turnover rates and mitochondrial membranepotential stability.

Depending on experimental conditions, PHENICARBAZIDE may alter metabolic flux distribution, cytoskeletal tension, vesicular transport efficiency, chromatinaccessibility patterns and geneexpression networks related to stress responses, inflammation, apoptosis, autophagy and metabolic adaptation.

Benefits and Advantages

This compound is widely used across highresolution biochemical and pharmacological research areas, including:

  • Receptorligand interaction analysis and affinitymapping
  • Detailed enzymekinetics profiling and catalyticpathway evaluation
  • Mitochondrialdynamics studies, ATPflux modelling and oxidativestress research
  • Integrated multiomics applications (transcriptomics, metabolomics, proteomics, phosphoproteomics)
  • Cytoskeletal and membranemechanics modelling
  • Apoptosis, necroptosis, ferroptosis and autophagy signalling pathway studies
  • SAR (structureactivity relationship) and molecularoptimisation pipelines
  • Mechanistic pharmacodynamic modelling and thresholdactivation experiments

Side Effects and Risks

Laboratoryobserved risks include:

  • Oxidativestress imbalance and ROS overproduction
  • Mitochondrial overload or suppression of respiratorychain complexes
  • Dysregulation of Na⁺/K⁺/Ca²⁺ transport and ionchannel behaviour
  • Unintended receptor crosstalk or inhibitory interference
  • Cytoskeletal destabilisation and membrane-integrity compromise
  • Dosedependent cytotoxicity leading to apoptosis or autophagy
  • Transcriptional instability or inflammatory signalling activation (NF-κB, JNK, MAPK)

Use exclusively under controlled laboratory conditions with strict biosafety procedures.

Only GMP materials will be supplied, logistics all according to GDP.

Datasheet


Molecular Formula

C8H9N3O2

Molecular Weight

151.17 g/mol

CAS Number

103-03-7

Storage Condition

Store in a cool, dry place. Keep container tightly closed. Protect from moisture and light.

Solubility

Solubility depends on solvent and conditions (e.g., pH). Please contact us for solvent-specific guidance.

Purity

Purity information is available upon request (COA).

Synonym

Phenicarbazide; 1-Phenylsemicarbazide; 2-Phenylhydrazinecarboxamide; anilinourea; Kryogenin

IUPAC/Chemical Name

anilinourea

InChl Key

AVKHCKXGKPAGEI-UHFFFAOYSA-N

InChl Code

InChI=1S/C7H9N3O/c8-7(11)10-9-6-4-2-1-3-5-6/h1-5,9H,(H3,8,10,11)

References

https://pubchem.ncbi.nlm.nih.gov/compound/61002;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download